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Purpose: To accelerate 19F‐MR imaging of inhaled perfluoropropane using 
compressed sensing methods, and to optimize critical scan acquisition parameters for 
assessment of lung ventilation properties.
Methods: Simulations were performed to determine optimal acquisition parameters for 
maximal perfluoropropane signal‐to‐noise ratio (SNR) in human lungs for a spoiled gra-
dient echo sequence. Optimized parameters were subsequently employed for 19F‐MRI 
of inhaled perfluoropropane in a cohort of 11 healthy participants using a 3.0 T scanner. 
The impact of 1.8×, 2.4×, and 3.0× undersampling ratios on 19F‐MRI acquisitions was 
evaluated, using both retrospective and prospective compressed sensing methods.
Results: 3D spoiled gradient echo 19F‐MR ventilation images were acquired at 1‐cm 
isotropic resolution within a single breath hold. Mean SNR was 11.7 ± 4.1 for scans 
acquired within a single breath hold (duration = 18 s). Acquisition of 19F‐MRI scans 
at shorter scan durations (4.5 s) was also demonstrated as feasible. Application of 
both retrospective (n = 8) and prospective (n = 3) compressed sensing methods dem-
onstrated that 1.8× acceleration had negligible impact on qualitative image appear-
ance, with no statistically significant change in measured lung ventilated volume. 
Acceleration factors of 2.4× and 3.0× resulted in increasing differences between 
fully sampled and undersampled datasets.
Conclusion: This study demonstrates methods for determining optimal acquisition 
parameters for 19F‐MRI of inhaled perfluoropropane and shows significant reduc-
tion in scan acquisition times (and thus participant breath hold duration) by use of 
compressed sensing.
K E Y W O R D S
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1 |  INTRODUCTION
Respiratory diseases are a leading cause of morbidity and 
mortality worldwide.1 Clinically, computed tomography 
(CT) and nuclear medicine techniques (e.g. planar scintig-
raphy and single photon emission computed tomography) 
facilitate assessment of both structural and functional prop-
erties of the lungs and are used routinely to aid diagnosis and 
monitoring of treatment response. However, these methods 
are limited by their reliance on ionizing radiation, restricting 
longitudinal or serial use.
Magnetic resonance imaging is increasingly recognized as 
a potential radiation‐free approach to the investigation of pul-
monary disease. Specifically, hyperpolarized gas MRI is well 
established in research settings, permitting the study of re-
gional ventilation across a variety of respiratory pathologies,2-4 
yet the requirement for gas polarization equipment and exper-
tise presents potential barriers to routine clinical application.
19F‐MRI of inhaled perfluoropropane is an emerging 
method for assessment of ventilation properties in humans.5,6 
This technique uses an inert, thermally polarized gas with 
multiple chemically equivalent 19F nuclei. The short in vivo 
T1 relaxation time of perfluoropropane (~12 ms at 3.0 T)
5 
permits short repetition time (TR), allowing a high degree of 
signal averaging and thus image acquisition without the need 
for hyperpolarization. Previous studies have demonstrated 
the feasibility of this approach to assess regional gas distri-
bution5,6 and washout dynamics7 in the lungs of healthy vol-
unteers and patients with respiratory disease. These human 
studies have built upon comprehensive preclinical8-12 and ex 
vivo13 studies that demonstrated the technical approach and 
characterized physical and MR properties of in vivo fluoro-
carbon gases. Nonetheless, MRI of inhaled perfluoropropane 
remains challenging, largely driven by its short in vivo T2
* 
relaxation properties (~2 ms at 3.0 T).5
As with all MRI techniques, acquisition parameter choice 
fundamentally impacts scan efficiency and resultant SNR. 
Understanding the interdependency of scan acquisition pa-
rameters is therefore central to maximizing performance 
of this methodology. Compressed sensing (CS) methods 
can further exploit the sparsity of MR images under math-
ematical transformation,14 reducing the amount of raw data 
acquired for a given matrix size while preserving image 
quality and content.15,16 This has potential substantially to 
reduce breath hold duration,17 which may be invaluable for 
assessing patients with compromised ventilation by reduc-
ing scan times or improving spatial resolution. Compressed 
sensing has shown utility in hyperpolarized 3He and 129Xe 
lung imaging,18,19 where there is intrinsically high SNR. The 
degree to which undersampling and compressed sensing re-
construction can be applied with acceptable image fidelity is 
highly dependent on SNR and phase encoding matrix size.20 
19F‐MR ventilation imaging is characterized by lower SNR 
and smaller phase‐encoding matrices. Acceleration factors 
and phase encoding patterns validated for 3He‐MRI and 
129Xe‐MRI are unlikely to be acceptable for 19F imaging. 
This work evaluates CS for 19F‐MRI of inhaled perfluoropro-
pane for the first time.
In this study we assessed the impact of critical image ac-
quisition parameters on spoiled gradient echo (SPGR) scan 
performance by calculating the interdependent effects of 
bandwidth (BW), excitation pulse amplitude and flip angle 
(B1, θ), and repetition time (TR) on SNR of 
19F‐MRI scans of 
inhaled perfluoropropane. Additionally, we compared image 
SNR and measured lung ventilated volume and ventilation 
defect percentage (VDP) calculated from retrospectively and 
prospectively accelerated scans compared to fully sampled 
acquisitions to gauge utility of accelerated 19F‐MR ventila-
tion imaging.
2 |  METHODS
2.1 | 
19F‐MRI sequence optimization
The standard equation for the signal intensity elicited by a 
SPGR sequence21 was modified to calculate the maximal 
SNR achievable within a defined scan duration, SNRSPGR 
(Equation 1). Simulations were then performed using the 
modified equation to assess variation in SNRSPGR with change 
in acquisition parameters, and to determine the parameters 
necessary for optimal SNRSPGR. The total scan time (Tscan) 
was kept at an arbitrary constant, permitting assessment of 
scan performance variability within the finite scan time im-
posed by breath hold acquisitions (e.g. <20 s).
where Nx, Ny, and Nz = number of frequency, and phase and 
partition encoding steps in each dimension; BW = receiver 
bandwidth (Hz/pixel); Tscan = total scan time (s); TEmin = 
minimum achievable echo time (s); T2
* = transverse relax-
ation time (s); T1 = longitudinal relaxation time (s); FOVx,y,z = 
field of view (mm); and TR = repetition time (s).
The scan acquisition parameters in Equation 1 are interde-
pendent, such that adjusting one parameter to increase scan 
performance can have a subsequent impact on other parame-
ters, with potential to reduce or negate SNR gains. For exam-
ple, TRmin is dependent on TEmin, which in turn is dependent 
on bandwidth, matrix size, and radiofrequency (RF) pulse 
and gradient properties.
SNRSPGR was calculated for flip angles (θ) between 
0 and 90 degrees, and for BW between 0 and 1500 Hz/
(1)
SNRSPGR∝FOVxFOVyFOVz
√
Tscan
N2
x
N2
y
N2
z
TRBW
(
1−e−TR∕T1
)
sin 휃(
1−e−TR∕T1 cos 휃
)e−TEmin∕T∗2
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pixel. The minimum echo time (TEmin) and repetition time 
(TRmin) were calculated as the minimum achievable on our 
scanner hardware based on RF pulse durations for B1 am-
plitudes between 0 and 10 µT, in accordance with scan-
ner gradient rise times and amplitudes, over the ranges of 
flip angle, bandwidth, and B1 amplitude assessed. TRmin 
was further bound by IEC 60601‐2‐33 specific absorption 
rate (SAR) limits22 applied to the 19F birdcage chest coil 
(Rapid Biomedical, Rimpar, Germany) in use at our center. 
The TR was therefore extended (i) to maintain whole‐body 
SAR limits under normal (2 W/kg) and first‐level (4 W/kg) 
operating modes and (ii) to maintain local torso limits 
under normal operating mode (10 W/kg).22
The field of view (FOVx,y,z) and matrix size (Nx,y,z) 
used in our simulations were chosen to be representative 
of 19F‐MRI scans performed at our center (detailed later). 
Perfluoropropane T1 and T2
* were based on values observed 
in previously published human studies at 3.0 T (12.4 ms and 
2.2 ms, respectively).5
The variation in SNRSPGR with change in θ, BW and TR 
was determined for a nonselective block RF pulse with B1 
amplitude of 4 μT, corresponding to the B1 used in our 
human studies (outlined later). Acquisition parameters for 
optimal SNRSPGR were subsequently determined. The impact 
of changing B1 amplitude on optimal SNRSPGR was also cal-
culated over a B1 range of 0 to 10 μT.
2.2 | 
19F‐MRI of inhaled perfluoropropane 
in healthy volunteers
Ethical approval for this study was granted by the Newcastle 
and North Tyneside 2 Research Ethics Committee and the 
NHS Health Research Authority. A total of 11 healthy volun-
teers (3 males, aged 25 to 46, mean = 33; 8 females, aged 24 
to 63, mean = 34) were screened for study eligibility across 
two research sites (Newcastle and Sheffield) and provided 
written informed consent to participate. All participants were 
nonsmokers in good health with no history of respiratory dis-
ease and no contraindications to MRI. Body weights were 
maintained within lower and upper weight limits specified 
by the RF coil manufacturer (50 kg and 100 kg, respectively).
Participants were invited to attend a single MRI scan 
session at one of the two research centers, during which 
they underwent conventional 1H‐MRI and 19F‐MRI scans, 
performed using a Philips Achieva (Newcastle) or Philips 
Ingenia (Sheffield) 3.0 T MRI scanner and chest bird-
cage 19F/1H coil (Rapid Biomedical, Rimpar, Germany). 
1H images were acquired using a multislice SPGR sequence 
(TE = 2.3 ms; TR = 5.1 ms; FOV = 450 × 450 × 300 mm; 
resolution = 192 × 96 × 30, reconstructed to 256 × 256 × 30; 
BW = 450 Hz/pixel; flip angle = 40°; scan duration = 15 s) 
with standard elliptical window21 after instructing partici-
pants to perform a breath hold at total lung capacity.
Participants were then asked to inhale a clinical grade 79% 
perfluoropropane/21% oxygen gas mixture (BOC Special 
Products, Guilford, United Kingdom), which involved up to 
five inhalation sessions during the MRI scan session, where 
one (retrospective scan acceleration measurement) or two 
(prospective scan acceleration measurements) of the inhala-
tion sessions were used to generate data for the study reported 
here. The remaining inhalation sessions were employed for 
other method development or research study purposes. Each 
inhalation session lasted less than 1 min, comprising three 
deep breaths of the gas via a nonrebreathe valve and mouth-
piece (Hans Rudolf, Shawnee, KS), followed by a breath hold 
at total lung capacity. 19F‐MR images were subsequently ac-
quired using a 3D SPGR sequence (1 cm isotropic resolu-
tion; FOV = 40 × 32 × 25 cm, zero‐filled to a reconstruction 
resolution of 0.36 × 0.36 × 1 cm; matrix = 112 × 90 × 25). 
The optimized acquisition parameters derived from simula-
tion studies were TE = 1.7 ms; TR = 7.5 ms; BW = 500 
Hz/pixel; flip angle = 50°, nonselective block RF pulse with 
a B1 amplitude of 4 μT. The duration of a single 3D gradient 
echo image was 4.5 s. Scans were acquired with four signal 
averages in total (scan duration = 18 s).
2.3 | Compressed sensing for accelerated 
19F‐MRI
Fully sampled k‐space data were acquired from eight 
participants in an 18‐s scan (number of signal averages, 
NSA = 4). The data were retrospectively undersampled in 
both phase encoding directions (i.e. ky and kz, correspond-
ing to physical directions right‐left and anterior‐posterior 
respectively, 32 × 25 matrix). The undersampling schemes 
were designed to create an incoherent sampling pattern 
possible with standard Fourier transformation using a uni-
form density Poisson disc with a fully sampled center.23 
Although our previous work has used variable density 
Poisson discs to reflect the underlying distribution of 
k‐space,17 the small matrix size used for this application pro-
vided too few samples at the edge of k‐space. Three degrees 
of undersampling were considered (1.8×, 2.4×, and 3.0×, 
sampling patterns shown in Figure 1), which would lead to 
breath holding times of 10 s, 7.5 s, and 6 s, respectively, with 
four averages. The sampling patterns were executed within 
a standard elliptical window for 3D gradient echo and there 
was full sampling of a central 8 × 7 region. A full acquisi-
tion with elliptical window has 592 phase encodes. Where 
undersampled data were acquired prospectively, a cus-
tom pulse sequence, which could faithfully reproduce the 
undersampled phase encode patterns to reduce the acquisi-
tion time, was used.
The incoherently undersampled data were reconstructed 
using an L1‐ESPIRiT algorithm with wavelet regularization 
as described in17 performed by minimizing:
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where yi is the acquired data, m is the reconstructed image space 
to find, F is a Fourier transform operator, and D is an operator 
that selects only those locations where data have been acquired 
(to match yi).
24 The Daubechies‐4 wavelet was used as the spar-
sifying transform, Ψ, and the weighting between the fit to the 
data and the sparsity of m in the wavelet domain was provided 
by λ. While there are many possible transforms that can sparsify 
MRI data, the Daubechies‐4 wavelet is computationally unde-
manding and has proven excellent performance across a range of 
compressed sensing applications in MRI.15,17,24,25 Randomized 
shifting of the wavelet transform was used to approximate 
translation‐invariant wavelets and prevent the appearance of 
structured artefacts within the reconstructed images.25,26 Fifty 
iterations were used to ensure convergence of the solution. In 
order to determine the optimal value of the wavelet weighting 
parameter, λ, the retrospectively sampled raw data were recon-
structed with several different values of λ and the root mean 
square error was calculated between the fully sampled and un-
dersampled data, using a signal intensity threshold to ensure 
only lung signals were evaluated. Lambda (λ) was chosen to 
minimize the root mean square error and an optimal value of 
0.05 was used throughout.
The fully sampled and retrospective accelerated recon-
structions were compared by subtraction and the apparent 
SNR measured. The SNR achieveable in 18 s (NSA = 4) of 
19F‐MR images was determined for all participants. Regions 
of interest 4 cm in diameter were placed in the center of the left 
lung (signal) and below the lung (noise) and SNR calculated 
using in‐house software developed in Matlab (Mathworks 
Inc., Natick, MA) using the equation SNR = 0.66 × mean 
signal amplitude/standard deviation of the noise, where 0.66 
is the Rayleigh distribution correction.27
Images acquired using optimized 19F scan parameters 
were also reconstructed from the first signal average (4.5 s) 
of the dataset.
A prospectively undersampled 3D gradient echo scan 
was acquired from a further three participants using the 1.8× 
acceleration scheme and NSA = 4 (scan duration = 10 s), 
using a custom pulse sequence to perform the selective phase 
encodings for the undersampling scheme in Figure 1,23 in ad-
dition to a fully sampled dataset acquired in a separate breath 
hold.
2.4 | Measurement of lung ventilated 
volume and ventilation defect percent
The ventilated volumes of the fully sampled and undersam-
pled 1.8× CS data were measured using an open‐source 
semiautomated 3D segmentation tool (ITK‐SNAP).28 A 
signal threshold of 3 SD below the mean signal from each 
image was adopted for the purpose of calculating ventilated 
lung volumes (L) of inhaled perfluoropropane. The trachea 
and main bronchi were excluded from the analysis through 
manual segmentation. A paired t test was conducted to as-
sess for significant change in measured ventilated volumes 
between the fully sampled and retrospectively 1.8× under-
sampled images. Measurements of lung VDP were calcu-
lated as the difference between total lung volume and lung 
ventilated volume, where total and ventilated lung volume 
were calculated from coregistered 1H‐MRI and 19F‐MRI 
datasets by a semiautomated approach using in‐house soft-
ware developed in Matlab.
3 |  RESULTS
Figure 2 shows the results of simulations investigating the 
relationship between SPGR acquisition parameters and 
19F‐MRI scan SNR performance. Figure 2A shows the impact 
of flip angle and acquisition bandwidth on SNR (shown in 
colorscale) and SAR (z‐axis) for scans performed with a nom-
inal B1 of 4 μT. Maximal SNR is observed at an acquisition 
bandwidth of 500 Hz/pixel and a flip angle of 40°. The data 
demonstrate a sharp decrease of SNR with reduction of flip 
angle slightly below optimal, but a less marked reduction with 
flip angle increasing above the theoretical optimum. Thus, the 
use of a flip angle slightly higher than the predicted optimal 
value was considered beneficial for our in vivo applications, 
where B1 inhomogeneity is present. Figure 2B shows the im-
pact of B1 amplitude on optimal values of TR, where relative 
SNR is shown in colorscale and plots are drawn for three SAR 
limits (2, 4, and 10 W/kg, respectively). Scan performance 
shows the greatest dependence on B1 amplitude below 2 μT, 
with diminishing SNR gains for B1 amplitudes above this 
threshold. The impact of SAR limits on acquisition param-
eters is apparent as an abrupt increase in TR and flip angle 
above a threshold B1 amplitude, as scan duty cycle is reduced 
to accommodate elevated SAR arising from higher B1.
Figure 3A demonstrates typical 19F‐MR images from 
one participant, acquired in 4.5 s (NSA = 1) using a 3D 
‖yi−DFm‖
2
2
+휆‖Ψm‖
1
F I G U R E  1  Phase encoding undersampling schemes shown for 
1.8×, 2.4×, and 3.0× CS schemes; CS, compressed sensing
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SPGR scan with optimized acquisition parameters. The B1 
amplitude was 4 μT, with power deposition kept within local 
torso limits (10 W/kg) as specified by IEC 60601‐2‐33.22 
Mean SNR was 7.7. A single slice from the 3D 19F‐MRI 
dataset, superimposed on an anatomical 1H image, is shown 
in Figure 3B.
Figure 4 shows a single coronal slice from a fully sampled 
lung volume (NSA = 4, scan duration = 18 s) in one healthy 
participant, alongside comparative images resulting from 
retrospectively applied compressed sensing (undersampling 
ratios of 1.8×, 2.4×, and 3.0×). Subtraction images demon-
strate that the 1.8× undersampled dataset closely matches the 
fully sampled dataset. Greater differences can be observed 
between the fully sampled and undersampled datasets as the 
acceleration factor increases beyond 1.8×, with increasing 
root mean square error between the fully sampled and ac-
celerated image pairs. The root mean square error values in 
Figure 4 have been expressed as multiples of that for the 1.8× 
undersampling for ease of comparison. Similar results were 
obtained across the eight participants (SNR 10.8 ± 3.8 and 
11.2 ± 3.7 for fully and retrospectively undersampled data-
sets, respectively), such that the 1.8× undersampling ratio 
was considered most appropriate for acceleration purposes. 
Single coronal slices from 3D datasets from three repre-
sentative participants are shown in Figure 5, with the 1.8× 
undersampled datasets demonstrating negligible differences 
when compared to the fully sampled datasets. Table 1 shows 
SNR, ventilated volume, and VDP measurements calculated 
from fully sampled and retrospectively accelerated datasets 
for each of the eight participants in the group. Ventilated 
volume and VDP values calculated from retrospectively ac-
celerated datasets were close to those calculated from fully 
sampled datasets, though the majority of ventilated volume 
measurements calculated from 1.8× undersampled datasets 
were slightly lower than those calculated from fully sampled 
data, and corresponding VDP measurements slightly higher 
in undersampled datasets compared to fully sampled data. 
These differences were not statistically significant.
Figure 6A shows single coronal slices from prospective 
1.8× accelerated 3D acquisitions from three participants, 
F I G U R E  2  A, Relative scan SNR (colorscale) achievable in a fixed acquisition time over a range of flip angles and acquisition bandwidths 
for a 3D SPGR acquisition sequence. Scan SAR (shown in the vertical axis) was limited to local and torso SAR limits of 10 W/kg by extension of 
scan repetition time. SAR isolines highlight positions of 2, 4, and 10 W/kg. B,  Relative scan SNR (colorscale) achievable over a range of excitation 
B1 values (x‐axis) with optimal (shortest achievable) TR for SAR = 2, 4, and 10 W/kg. The point at which maximum SNR is reached is marked (×) 
for each SAR level; SAR, specific absorption rate; SNR, signal‐to‐noise ratio; SPGR, spoiled gradient echo; TR, repetition time
F I G U R E  3  A, Coronal slices from a 3D 19F SPGR acquisition of 4.5‐s duration, acquired from a healthy volunteer. Mean SNR was 7.7. B, 
Healthy volunteer lung image generated from combined single slices of 3D 19F and 1H SPGR scans; SNR, signal‐to‐noise ratio; SPGR, spoiled 
gradient echo
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alongside corresponding fully sampled datasets acquired in 
a separate breath hold. The accelerated datasets have com-
parable visual appearance to the undersampled datasets. 
Subtraction images between the fully sampled and accelerated 
datasets were not generated as data were acquired in separate 
breath holds and thus lung spatial alignment and inflation are 
not matched. The SNR of prospectively acquired undersam-
pled datasets was 13.4 ± 4.0, comparable to the fully sampled 
datasets in these participants, 14.1 ± 5.0. Figure 6B shows an 
entire prospectively accelerated 19F‐MRI dataset from one of 
the three participants, demonstrating whole‐lung coverage in 
a 10‐s duration scan. Table 2 shows SNR, ventilated volume, 
and VDP measurements calculated from fully sampled and 
prospectively accelerated datasets for each of the three par-
ticipants in the group.
A paired‐samples t test demonstrated no significant dif-
ference in lung ventilated volume measurements made from 
eight fully sampled (mean = 5.0 L, SD = 1.2 L) and 1.8× 
retrospectively undersampled (mean = 4.9 L, SD = 1.1 L) 
lung 19F‐MRI datasets (p = .59). The lung ventilated 
volume measurements calculated from 1.8× prospectively 
undersampled acquisitions in three participants (mean = 5.0 L, 
SD = 0.6 L) closely matched those from the fully sampled 
acquisitions in these participants (mean = 5.1 L, SD = 0.7 L) 
and the difference in volume between the two groups was not 
statistically significant (p = .11). Figure 7 shows (A) correla-
tion and (B) Bland‐Altman plots of ventilated volume mea-
sured from fully sampled and 1.8× undersampled datasets for 
the eight participants. The bias between undersampled and 
fully sampled datasets by Bland‐Altman analysis (0.05 L) 
was not statistically significant.
Figure 8 shows a 3D image dataset reconstructed from 
a single average (NSA = 1) of the dataset used to generate 
Figure 3, with 1.8× retrospective undersampling. The scan 
duration of a corresponding prospective acquisition with this 
undersampling scheme would be 2.5 s. The images show 
good visual correspondence with the fully sampled images 
shown in Figure 3.
4 |  DISCUSSION
We have modeled 19F‐MRI scan performance to optimize 
imaging of inhaled perfluoropropane with a SPGR pulse se-
quence at 3.0 T and demonstrated the potential for 19F‐MRI 
scan acceleration through compressed sensing methods in 
a group of healthy participants. The interdependent rela-
tionship between MR acquisition parameters is particularly 
marked for perfluoropropane imaging because of inherently 
short relaxation rates (T1 and T2
*) and operation at or near 
SAR limit boundaries. Our SNR calculations enable deter-
mination of optimal acquisition parameter values based on 
hardware performance, providing a robust and comprehen-
sive understanding of their interdependence.
The short T1 of perfluoropropane has the advantage of 
permitting short TR, and thus a high degree of signal av-
eraging, with minimum TR determined by the SAR lim-
its of our hardware configuration. Our calculations show 
that short TR (<10 ms) and large flip angles (40° to 50°) 
are required for maximal scan efficiency, and that the short 
T2
* of perfluoropropane causes acquisition bandwidth and 
F I G U R E  4  19F lung images reconstructed from NSA = 4 
fully sampled healthy volunteer scan data and from retrospective 
undersampled reconstructions of the same dataset (undersampling of 
1.8×, 2.4×, and 3.0×), and images of the difference between CS and 
fully sampled images shown at 5× vertical scale. Relative root mean 
square error provides an index of similarity between fully sampled 
and undersampled images, scaled to the 1.8× dataset; CS, compressed 
sensing; NSA, number of signal averages
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excitation pulse duration to have a strong impact on scan 
performance. A reduction in RF pulse duration through 
increased B1 amplitude offers diminishing returns to scan 
efficiency above approximately 2 μT on our hardware con-
figuration. This effect is significant as scanner multinuclear 
(nonproton) RF amplifiers typically have considerably 
lower power output than their 1H counterparts, such that the 
maximum achievable B1 may be modest for 
19F torso coils.
19F‐MR images of inhaled perfluoropropane acquired 
from our group of healthy participants showed a mean SNR 
of 11.7 ± 4.1 for a scan performed within a single breath hold 
(18 s, NSA = 4) with 1‐cm isotropic acquisition resolution. A 
direct SNR comparison of our scan performance with previ-
ously published 19F‐MRI studies is challenging as a result of 
differences in RF coil hardware, scanner field strength, and 
scan voxel sizes and of a lack of comprehensive information 
regarding choice of scan parameters. Nonetheless, the optimi-
zation approach we describe provides a framework to ensure 
maximal scan performance is achieved for a given hardware 
configuration. In addition, we have demonstrated that gains 
F I G U R E  5  Coronal slices from 
3D 19F acquisitions (NSA = 4) from 
three representative participants, showing 
fully sampled acquisitions (top), images 
reconstructed from 1.8× retrospective 
undersampling (center), and difference 
images between fully sampled and 
undersampled reconstructions at 5× vertical 
scale (bottom); NSA, number of signal 
averages
Participant
Fully sampled Retrospectively accelerated
SNR VV / L VDP / % SNR VV / L VDP / %
A 13.5 4.67 0.6 13.8 4.49 1.1
B 5.8 4.70 1.5 6.4 4.35 1.5
C 15.9 5.65 0.5 17.0 5.47 2.7
D 8.6 7.76 2.1 7.9 7.26 3.7
E 7.9 4.36 2.4 8.9 3.92 2.6
F 7.6 6.33 1.7 9.1 5.89 1.7
G 14.3 3.82 2.9 14.4 3.48 2.3
H 13.1 6.27 0.4 12.5 6.07 0.7
Mean 10.8 5.45 1.5 11.3 5.12 2.0
Abbreviations: SNR, signal‐to‐noise ratio; VDP, ventilation defect percentage; VV, lung ventilated volume.
T A B L E  1  Signal‐to‐noise ratio, lung ventilated volume, and ventilation percentage defect measurements calculated from fully‐sampled and 
retrospectively accelerated scan datasets from eight healthy volunteer participants
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F I G U R E  6  A, Coronal slices from 3D fully sampled and prospectively 1.8× accelerated scans (NSA = 4), acquired from three healthy 
volunteers in separate breath holds. Difference images are not shown because of lack of registration between images resulting from minor 
difference in lung inflation levels between breath holds). B, A 3D 19F‐MRI scan acquired with 1.8× prospective acceleration (NSA = 4) in a scan of 
10‐s duration, showing whole‐lung coverage at 1‐cm isotropic resolution; NSA, number of signal averages
Participant
Fully sampled Prospectively accelerated
SNR VV/L VDP/% SNR VV/L VDP/%
I 10.0 5.27 1.3 9.9 5.13 1.9
J 19.7 5.75 0.8 17.7 5.56 1.2
K 12.5 4.33 0.3 12.6 4.29 2.7
Mean 14.1 5.12 0.8 13.4 4.99 1.9
Abbreviations: SNR, signal‐to‐noise ratio;VDP, ventilation defect percentage; VV, lung ventilated volume.
T A B L E  2  Signal to noise ratio, lung ventilated volume, and ventilation defect percentage measurements calculated from fully sampled and 
prospectively accelerated scan datasets from three healthy volunteer participants
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in temporal resolution are achievable through the use of com-
pressed sensing methods. Specifically, the application of a 
1.8× undersampling scheme and compressed sensing recon-
struction is able to preserve image quality and apparent SNR. 
As well as improving temporal resolution in dynamic imag-
ing, the acceleration offered by compressed sensing has po-
tential to reduce breath hold duration (particularly significant 
for patients unable to comply with longer breath holds), or to 
improve SNR by enabling a greater degree of signal averag-
ing during breath hold. The achievable acceleration for this 
19F‐MRI protocol is, as expected, not as great as in previous 
hyperpolarized gas MRI studies,18,19 reflecting the inherently 
lower signal generated by thermally polarized perfluoropro-
pane and the relatively small phase‐encoding matrix used. 
Nonetheless, our data clearly demonstrate the utility of com-
pressed sensing for 19F‐MRI of perfluoropropane, despite 
these limitations.
Our data show the majority of VDP values calculated from 
1.8× undersampled datasets were slightly higher than those 
calculated from fully sampled data, though the difference in 
VDP between the two groups was not statistically significant. 
Scan acceleration introduced subtle signal intensity changes 
in 19F‐MRI scans that had a small effect on the position of the 
boundary between ventilated and nonventilated regions, man-
ifest as a small decrease in lung ventilated volume. The VDP 
measurements of the prospectively accelerated group did not 
show a statistically significant difference from those of the 
retrospectively accelerated group (t test, p  = .87). Future 
F I G U R E  7  A, correlation and B, Bland‐Altman plots showing comparison of ventilated volumes measured calculated from fully sampled 
and 1.8× retrospectively undersampled datasets. The correlation plot shows an isoline between measurements. The calculated correlation 
coefficient was 0.982. The Bland‐Altman plot shows estimated bias (0.05 L, — — —) and 95% limits of agreement (±0.47 L, · · ·)
F I G U R E  8  Retrospective 1.8× undersampling of the NSA = 1 dataset shown in Figure 3 (shown with the same window and level scaling as 
Figure 3), corresponding to a 2.5‐s acquisition duration for a prospective acquisition; NSA, number of signal averages
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studies employing fully sampled and accelerated 19F‐MRI on 
patients with ventilation defects arising from respiratory dis-
ease will provide insight into the extent to which this effect 
might impact measurements made from a clinical cohort and 
allow testing of mitigation strategies if required (for example, 
alteration of region of interest threshold boundary based on 
degree of acceleration). Nonetheless, the difference in mean 
VDP between accelerated and fully sampled scans remains 
small (2.0% versus 1.5%, respectively).
Studies have demonstrated that non‐Cartesian acquisition 
techniques such as ultra short echotime (UTE) imaging29 hold 
value in 19F‐MRI of perfluoropropane as short echo times 
minimize T2
*‐related signal losses. These approaches might 
also provide opportunities for higher acceleration factors. 
Further gains in scan performance may be achieved through 
the use of multichannel receive array coils, improving sen-
sitivity through a smaller effective receive coil volume and 
enabling additional scan acceleration via parallel imaging 
methods. The efficacy of multichannel receive hardware for 
19F‐MR imaging has already been successfully demonstrated 
in studies of patients with chronic obstructive pulmonary dis-
ease.7 The possibility of using this approach in combination 
with compressed sensing methods14 holds significant poten-
tial for additional scan acceleration and optimization.
The ability to breathe perfluoropropane with oxygen 
over a prolonged, dynamic image acquisition has recently 
shown promise in providing a quantitative measure of ven-
tilation defects in patients with COPD.7 Such dynamic im-
aging has an advantage over hyperpolarized gas MRI in 
that the thermally polarized perfluoropropane exhibits scan 
signal intensity that is proportional solely to its concen-
tration and relaxation properties within the lungs, whereas 
signal intensity of a hyperpolarized gas exhibits loss of po-
larization through RF‐mediated and T1‐mediated effects. 
The short duration of our optimized scan protocol may be 
suited to dynamic imaging.
19F‐MRI of inhaled perfluoropropane represents a nascent 
field, offering new opportunities for assessing pulmonary 
ventilation properties in both healthy volunteers and patients 
with respiratory disease. The optimization approach em-
ployed in our studies can be applied to different RF coil hard-
ware configurations (including the combined use of array 
receive coils), different scanner manufacturers and models, 
and different scan acquisition methods to produce a tailored, 
optimized scan protocol. Improvements in scan optimization 
and acceleration offer considerable scope for future clinical 
application of this technique.
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